Successful treatment of disseminated central nervous aspergillosis in a patient with acute myeloblastic leukemia

Leukemia and Lymphoma

Volumn 27, Issue 1-2, 1997, Pages 191-194

  Mahlknecht, Ulrich ^a,b   Von Lintig, Friederike ^a   Mertelsmann, Roland ^a   Lindemann, Albrecht ^a   Lübbert, Michael ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Aspergillus; Brain abscess; Immunosuppression; Leukemia; Liposomal amphotericin B; Neutropenia

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CREATININE; POTASSIUM;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; ASPERGILLOSIS; BRAIN ABSCESS; CASE REPORT; CENTRAL NERVOUS SYSTEM INFECTION; CREATININE BLOOD LEVEL; FEMALE; HUMAN; NEUTROPENIA; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0030831051     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709068287     Document Type: Article

References (13)

1. Hagensee, M. E., Bauwens, J. E., Kjos, B. and Bowden, R. A. (1994). Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clinical Infectious Diseases, 19(3), 402-8.
2. Coleman, J. M., Hogg, G. G., Rosenfeld, J. V. and Waters, K. D. (1995). Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole. and radical surgery-case report and review of the literature. Neurosurgery, 36(4), 858-63.
3. Camarata, P. J., Dunn, D. L., Farney, A. C., Parker, R. G. and Seljeskog, E. L. (1992). Continual intracavitary administration of amphotericin B as an adjunct in the treatment of aspergillus brain abscess: case report and review of the literature. Neurosurgery, 31(3), 575-9.
4. Denning, D. W. and Stevens, D. A. (1990). Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Reviews of Infectious Diseases, 12(6), 1147-1201.
5. Jennings, T. S. and Hardin, T. C. (1993). Treatment of aspergillosis with itraconazole. The Annals of Pharmacotherapy, 27(10), 1206-11.
6. de Marie, S. (1996). Liposomal and lipid-based formulations of amphotericin B. Leukemia, 10(2), 93-6.
7. Collette, N., Van der Auwera, P., Meunier, F., Lambert, C., Sculier, J. P. and Coune, A. (1991). Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. J. Antimicrob, Chemother, 27(4), 535-48.
8. Ashdown, B. C., Tien, R. D. and Felsberg, G. J. (1994). Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. American Journal of Roentgenology, 162(1), 155-9.
9. Torre-Cisneros, J., Lopez, O. L., Kusne, S., Martinez, A. J., Starzl, T. E., Simmons, R. L. and Martin, M. (1993). CNS aspergillosis in organ transplantation: a clinicopathological study. Journal of Neurology, Neurosurgery and Psychiatry, 56(2), 188-93.
10. Anaissie, E. (1992). Opportunistic mycoses in the immuno-compromised host: experience at a cancer center and review. Clinical Infectious Diseases, 14(1), 43-53.
11. Gennuso, R., Spigelman, M. K., Chinol, M., Zappzulla, R. A., Nieves, J., Vallabhajosula, S., Paciucci, A. P., Goldsmith, S. J. and Holland, J. F. (1993). Effect of blood-brain barrier and blood-tumor barrier modification on central nervous system liposomal uptake. Cancer Investigations, 11, 118-128.
12. Sakamoto, A. and Ido, T. (1993). Liposome targeting to rat brain: effect of osmotic opening of the blood-brain barrier. Brain Research, 629, 171-175.
13. Proffitt, R. T., Satorius, A., Chiang, S. M., Sullivan, L. and Adler-Moore, J. P. (1991). Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother., 28(suppl. B), 49-61.